Crescent Capital [CCAP] vs SRH Total Return [STEW] Detailed Stock Comparison
Crescent Capital
NASDAQ
Loading...
SRH Total Return
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 18 vital metrics comparison: Crescent Capital wins in 9 metrics, SRH Total Return wins in 8 metrics, with 0 ties. Crescent Capital appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Crescent Capital | SRH Total Return | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 12.75 | 5.45 | SRH Total Return |
| Price-to-Book Ratio | 0.78 | 0.83 | Crescent Capital |
| Debt-to-Equity Ratio | 122.44 | 10.77 | SRH Total Return |
| PEG Ratio | -0.50 | N/A | N/A |
| Profit Margin (TTM) | 24.12% | 928.40% | SRH Total Return |
| Operating Margin (TTM) | 75.45% | 34.92% | Crescent Capital |
| EBITDA Margin (TTM) | 75.45% | 34.92% | Crescent Capital |
| Return on Equity | 5.98% | 16.36% | SRH Total Return |
| Return on Assets (TTM) | 5.27% | 0.34% | Crescent Capital |
| Free Cash Flow (TTM) | $58.91M | $62.50M | SRH Total Return |
| Dividend Yield | 16.67% | 3.62% | Crescent Capital |
| 1-Year Return | -17.43% | 16.86% | SRH Total Return |
| Price-to-Sales Ratio (TTM) | 3.07 | 50.45 | Crescent Capital |
| Enterprise Value | $1.44B | $0 | Crescent Capital |
| EV/Revenue Ratio | 7.86 | 0.00 | SRH Total Return |
| Revenue per Share (TTM) | $5 | $0 | Crescent Capital |
| Earnings per Share (Diluted) | $1.19 | $3.30 | SRH Total Return |
| Beta (Stock Volatility) | 0.60 | 0.95 | Crescent Capital |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Crescent Capital vs SRH Total Return Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Crescent Capital | 0.07% | 3.84% | 5.20% | -2.88% | -24.20% | -21.08% |
| SRH Total Return | 0.50% | 1.52% | 2.49% | 1.34% | 6.47% | 13.49% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Crescent Capital | -17.43% | -13.02% | 24.16% | -7.56% | -7.56% | -7.56% |
| SRH Total Return | 16.86% | 45.18% | 75.12% | 131.63% | 210.82% | 169.60% |
Performance & Financial Health Analysis: Crescent Capital vs SRH Total Return
| Metric | CCAP | STEW |
|---|---|---|
| Market Information | ||
| Market Cap | $562.22M | $1.73B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 165,120 | 84,340 |
| 90 Day Avg. Volume | 228,990 | 88,530 |
| Last Close | $15.17 | $18.09 |
| 52 Week Range | $13.54 - $20.19 | $15.00 - $18.13 |
| % from 52W High | -24.86% | -0.22% |
| All-Time High | $21.24 (Oct 11, 2021) | $18.13 (Aug 19, 2025) |
| % from All-Time High | -28.58% | -0.22% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.12% | -0.07% |
| Quarterly Earnings Growth | -0.26% | N/A |
| Financial Health | ||
| Profit Margin (TTM) | 0.24% | 9.28% |
| Operating Margin (TTM) | 0.75% | 0.35% |
| Return on Equity (TTM) | 0.06% | 0.16% |
| Debt to Equity (MRQ) | 122.44 | 10.77 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $19.55 | $21.54 |
| Cash per Share (MRQ) | $0.26 | N/A |
| Operating Cash Flow (TTM) | $65.36M | $62.98M |
| Levered Free Cash Flow (TTM) | $58.51M | $2.92M |
| Dividends | ||
| Last 12-Month Dividend Yield | 16.67% | 3.62% |
| Last 12-Month Dividend | $2.41 | $0.62 |
Valuation & Enterprise Metrics Analysis: Crescent Capital vs SRH Total Return
| Metric | CCAP | STEW |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 12.75 | 5.45 |
| Forward P/E | 7.51 | N/A |
| PEG Ratio | -0.50 | N/A |
| Price to Sales (TTM) | 3.07 | 50.45 |
| Price to Book (MRQ) | 0.78 | 0.83 |
| Market Capitalization | ||
| Market Capitalization | $562.22M | $1.73B |
| Enterprise Value | $1.44B | $0 |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 7.86 | 0.00 |
| Enterprise to EBITDA | N/A | N/A |
| Risk & Other Metrics | ||
| Beta | 0.60 | 0.95 |
| Book Value per Share (MRQ) | $19.55 | $21.54 |
Financial Statements Comparison: Crescent Capital vs SRH Total Return
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | CCAP | STEW |
|---|---|---|
| Revenue/Sales | $7.13M | N/A |
| Cost of Goods Sold | N/A | N/A |
| Gross Profit | N/A | N/A |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | N/A | N/A |
| EBITDA | N/A | N/A |
| Pre-Tax Income | $4.41M | N/A |
| Income Tax | $501,000 | N/A |
| Net Income (Profit) | $3.90M | N/A |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | CCAP | STEW |
|---|---|---|
| Cash & Equivalents | $12.03M | N/A |
| Total Current Assets | N/A | N/A |
| Total Current Liabilities | N/A | N/A |
| Long-Term Debt | $902.95M | $223.55M |
| Total Shareholders Equity | $727.12M | $2.12B |
| Retained Earnings | $-232.01M | $1.60B |
| Property, Plant & Equipment | N/A | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | CCAP | STEW |
|---|---|---|
| Operating Cash Flow | $2.00M | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | $-15.13M | N/A |
| Debt Repayment | $-233.04M | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | CCAP | STEW |
|---|---|---|
| Shares Short | 121,167 | 33,263 |
| Short Ratio | 0.44 | 0.37 |
| Short % of Float | 0.01% | 0.00% |
| Average Daily Volume (10 Day) | 165,120 | 84,340 |
| Average Daily Volume (90 Day) | 228,990 | 88,530 |
| Shares Outstanding | 37.06M | 96.44M |
| Float Shares | N/A | N/A |
| % Held by Insiders | 0.13% | 0.47% |
| % Held by Institutions | 0.65% | 0.16% |
Dividend Analysis & Yield Comparison: Crescent Capital vs SRH Total Return
| Metric | CCAP | STEW |
|---|---|---|
| Last 12-Month Dividend | $2.41 | $0.62 |
| Last 12-Month Dividend Yield | 16.67% | 3.62% |
| 3-Year Avg Annual Dividend | $2.04 | $0.54 |
| 3-Year Avg Dividend Yield | 1.65% | 0.96% |
| 3-Year Total Dividends | $6.12 | $1.62 |
| Ex-Dividend Date | Aug 29, 2025 | Apr 23, 2025 |